Table 2.
Authors | Subjects enrolled (completed) | ADHD comorbid disordersa | Design | CLO daily dose | Efficacy measures | Safety measures | Efficacy | Side effects |
---|---|---|---|---|---|---|---|---|
Kurlan et al20 | 136 (117) | Chronic tic disorder | 16-week DB, CLO, MLP, CLO + MLP, placebo | CLO 0.25 mg CLO + MLP 0.28 mg Max 0.6 mg |
Multiple ADHD RS and psychological tests completed by researchers, teachers, self, and/or parents | Clinical reports, ECG, VS | CLO better than placebo for hyperactivity and impulsivity, MLP + CLO superior | Sedation, no significant ECG changes |
Connor et al22 | 24 | ODD or CD | 3-month SB, CLO, MLP, CLO + MLP, no placebo | Max 0.3 mg | Psychological tests, performance tests, and RS completed by parents and teachers | Clinical reports, side effects RS, ECG, VS | Significant improvement in ADHD, ODD, and CD symptoms for all three groups | CLO + MLP: increase in PR interval and bradycardia (clinically insignificant) |
Nair et al24 | 50 | ODD, CD, or seizures | 2-year DB crossover CLO vs CBZ, no placebo |
0.008 mg/kg | RS completed by researchers every 4 weeks | Clinical reports, echocardiogram, laboratory tests, chest x-ray, EEG | CLO effective for hyperactivity and impulsivity, but not for inattention | Side effects not stated |
Hazell et al23 | 67 (60) | ODD or CD | 6-week DB, CLO vs placebo as add-on | Min 0.10 mg Max 0.20 mg |
ADHD RS by parents and teachers | Clinical reports, side effects RS, VS | Greater reduction in hyperactivity and conduct in CLO group, not statistically significant | Drowsiness Dizziness |
Meere et al21 | 53 | ODD, CD, or depressive/anxiety disorder | 7-week, CLO, MLP, placebo | 0.004 mg/kg | GO-NO GO Behavioral test |
Clinical reports | CLO not effective | N/A |
Note: Subjects in all of the clinical trials had a diagnosis of ADHD and the comorbidities listed.
Abbreviations: ADHD, attention deficit and hyperactivity disorders; ODD, oppositional defiant disorder; CD, conduct disorder; DB, double-blind; ECG, electrocardiogram; EEG, electroencephalogram; SB, single-blind; CLO, clonidine; CBZ, carbamazepine; max, maximum; min, minimum; MLP, methylphenidate; N/A, not available; RS, rating scales; ECG, electrocardiogram; VS, vital signs.